PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease

被引:61
|
作者
Petta, Salvatore [1 ]
Valenti, Luca [2 ]
Marchesini, Giulio [5 ]
Di Marco, Vito [1 ]
Licata, Anna [1 ]
Camma, Calogero [1 ]
Barcellona, Maria Rosa [1 ]
Cabibi, Daniela [4 ]
Donati, Benedetta [2 ]
Fracanzani, Anna [2 ]
Grimaudo, Stefania [1 ]
Parrinello, Gaspare [3 ]
Pipitone, Rosaria Maria [1 ]
Torres, Daniele [3 ]
Fargion, Silvia [2 ]
Licata, Giuseppe [3 ]
Craxi, Antonio [1 ]
机构
[1] Univ Palermo, Di Bi MIS, Sez Gastroenterol, Palermo, Italy
[2] Univ Milan, Fdn Ca Granda IRCCS Osped Maggiore Policlin, Sect Internal Med, Dept Pathophysiol & Transplantat, Milan, Italy
[3] Univ Palermo, Dipartimento Biomed Med Interna & Specialist Di B, Palermo, Italy
[4] Univ Palermo, Dipartimento Patol Umana, Palermo, Italy
[5] Univ Bologna, Dipartimento Med & Gastroenterol, Bologna, Italy
来源
PLOS ONE | 2013年 / 8卷 / 09期
关键词
GAMMA-GLUTAMYL-TRANSFERASE; WALL THICKNESS; CARDIOVASCULAR-DISEASE; RISK; ASSOCIATION; HEPATITIS; EVENTS; HEART;
D O I
10.1371/journal.pone.0074089
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Aim: To evaluate if the presence of carotid atherosclerosis in patients with NAFLD, could be related to gene variants influencing hepatic fat accumulation and the severity of liver damage. Methods: We recorded anthropometric, metabolic and histological data(Kleiner score) of 162 consecutive, biopsy-proven Sicilian NAFLD patients. Intima-media thickness(IMT), IMT thickening(IMT >= 1 mm) and carotid plaques(focal thickening of >1.3 mm at the level of common carotid artery) were evaluated using ultrasonography. IL28B rs12979860 C>T, PNPLA3 rs738409 C>G, GCKR rs780094 C>T, LYPLAL1 rs12137855 C>T, and NCAN rs2228603 C>T single nucleotide polymorphisms were also assessed. The results were validated in a cohort of 267 subjects with clinical or histological diagnosis of NAFLD from Northern Italy, 63 of whom had follow-up examinations. Results: Carotid plaques, IMT thickening and mean maximum IMT were similar in the two cohorts, whereas the prevalence of diabetes, obesity, NASH, and PNPLA3 GG polymorphism(21% vs. 13%, p = 0.02) were significantly higher in the Sicilian cohort. In this cohort, the prevalence of carotid plaques and IMT thickening was higher in PNPLA3 GG compared to CC/CG genotype(53% vs. 32%, p = 0.02; 62% vs. 28%, p < 0.001, respectively). These associations were confirmed at multivariate analyses (OR2.94; 95% C. I. 1.12-7.71, p = 0.02, and OR4.11; 95% C. I. 1.69-9.96, p = 0.002, respectively), although have been observed only in patients <50years. Also in the validation cohort, PNPLA3 GG genotype was independently associated with IMT thickening in younger patients only (OR: 6.00,95% C. I. 1.36-29, p = 0.01), and to IMT progression (p = 0.05) in patients with follow-up examinations. Conclusion: PNPLA3 GG genotype is associated with higher severity of carotid atherosclerosis in younger patients with NAFLD. Mechanisms underlying this association, and its clinical relevance need further investigations.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease
    Petta, Salvatore
    Valenti, Luca
    Marchesini, Giulio
    Di Marco, Vito
    Licata, Anna
    Camma, Calogero
    Barcellona, Maria Rosa
    Cabibi, Daniela
    Donati, Benedetta
    Fracanzani, Anna Ludovica
    Grimaudo, Stefania
    Parrinello, Gaspare
    Pipitone, Rosaria Maria
    Torres, Daniele
    Fargion, Silvia
    Licata, Giuseppe
    Craxi, Antonio
    HEPATOLOGY, 2013, 58 : 506A - 506A
  • [2] PNPLA3 GG GENOTYPE IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Petta, S.
    Parrinello, G.
    Di Marco, V.
    Licata, A.
    Camma, C.
    Barcellona, M. R.
    Cabibi, D.
    Grimaudo, S.
    Pipitone, R. M.
    Torres, D.
    Marchesini, G.
    Licata, G.
    Craxi, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S547 - S547
  • [3] PNPLA3 GENOTYPE: RELATIONSHIP TO SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Al-Serri, Ahmad
    Day, Christopher P.
    Daly, Ann K.
    HEPATOLOGY, 2009, 50 (04) : 1167A - 1168A
  • [4] Hepatic copper and PNPLA3 in patients with non-alcoholic fatty liver disease
    Staettermayer, Albert
    Traussnigg, Stefan
    Aigner, Elmar
    Kienbacher, Christian
    Steindl-Munda, Petra E.
    Datz, Christian
    Wrba, Fritz
    Trauner, Michael
    Ferenci, Peter
    HEPATOLOGY, 2014, 60 : 609A - 609A
  • [5] PNPLA3 GG genotype is associated with higher incidence of cirrhosis and liver-related events among patients with non-alcoholic fatty liver disease
    Wijarnpreecha, Karn
    Li, Fang
    Lok, Anna
    Chen, Vincent
    JOURNAL OF HEPATOLOGY, 2023, 78 : S609 - S610
  • [6] DISEASE PHENOTYPE IS A BARRIER FOR ENROLLMENT IN EARLY CLINICAL TRIALS FOR ANTI-SENSE GENE THERAPIES IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH PNPLA3 GG GENOTYPE
    Samala, Niharika R.
    Vuppalanchi, Raj
    Smith, Emily R.
    Pike, Francis
    Gawrieh, Samer
    Vilar-Gomez, Eduardo
    Chalasani, Naga P.
    HEPATOLOGY, 2021, 74 : 1004A - 1005A
  • [7] PNPLA3 as a Genetic Determinant of Risk for Progression and Outcomes in Non-Alcoholic Fatty Liver Disease and Alcoholic Liver Disease
    Arora, Sumant S.
    Seay, Toni
    Crowley, Michael
    Edberg, Jeff
    Singal, Ashwani K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S555 - S555
  • [8] A Study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
    Mishra S.
    Yadav D.
    Gupta M.
    Mishra H.
    Sharma P.
    Indian Journal of Clinical Biochemistry, 2013, 28 (1) : 79 - 83
  • [9] Adiponutrin (PNPLA3) rs738409 genotype influences the metabolic activity of non-alcoholic fatty liver disease
    Nadasdi, A.
    Gal, V.
    Rosta, K.
    Harreiter, J.
    Kautzky-Willer, A.
    Somogyi, A.
    Fimeisz, G.
    DIABETOLOGIA, 2018, 61 : S567 - S568
  • [10] Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study
    Wagenknecht, Lynne E.
    Palmer, Nicholette D.
    Bowden, Donald W.
    Rotter, Jerome I.
    Norris, Jill M.
    Ziegler, Julie
    Chen, Yii-Der I.
    Haffner, Steven
    Scherzinger, Ann
    Langefeld, Carl D.
    LIVER INTERNATIONAL, 2011, 31 (03) : 412 - 416